141 related articles for article (PubMed ID: 16394520)
1. Non-methylated CpG motif packaged into fusogenic liposomes enhance antigen-specific immunity in mice.
Yoshikawa T; Imazu S; Gao JQ; Hayashi K; Tsuda Y; Okada N; Tsutsumi Y; Akashi M; Mayumi T; Nakagawa S
Biol Pharm Bull; 2006 Jan; 29(1):105-9. PubMed ID: 16394520
[TBL] [Abstract][Full Text] [Related]
2. Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects.
Storni T; Ruedl C; Schwarz K; Schwendener RA; Renner WA; Bachmann MF
J Immunol; 2004 Feb; 172(3):1777-85. PubMed ID: 14734761
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of antigen-specific immune responses using DNA-fusogenic liposome vaccine.
Yoshikawa T; Imazu S; Gao JQ; Hayashi K; Tsuda Y; Shimokawa M; Sugita T; Niwa T; Oda A; Akashi M; Tsutsumi Y; Mayumi T; Nakagawa S
Biochem Biophys Res Commun; 2004 Dec; 325(2):500-5. PubMed ID: 15530420
[TBL] [Abstract][Full Text] [Related]
4. Plasmids enriched with CpG motifs activate human peripheral blood mononuclear cells in vitro and enhance th-1 immune responses to hepatitis B surface antigen in mice.
Chen Z; Cao J; Liao X; Ke J; Zhu S; Zhao P; Qi Z
Viral Immunol; 2011 Jun; 24(3):199-209. PubMed ID: 21668361
[TBL] [Abstract][Full Text] [Related]
5. Methylated CpG-containing plasmid activates the immune system.
Cornélie S; Poulain-Godefroy O; Lund C; Vendeville C; Ban E; Capron M; Riveau G
Scand J Immunol; 2004 Feb; 59(2):143-51. PubMed ID: 14871290
[TBL] [Abstract][Full Text] [Related]
6. Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity.
Davila E; Celis E
J Immunol; 2000 Jul; 165(1):539-47. PubMed ID: 10861094
[TBL] [Abstract][Full Text] [Related]
7. A KALA-modified lipid nanoparticle containing CpG-free plasmid DNA as a potential DNA vaccine carrier for antigen presentation and as an immune-stimulative adjuvant.
Miura N; Shaheen SM; Akita H; Nakamura T; Harashima H
Nucleic Acids Res; 2015 Feb; 43(3):1317-31. PubMed ID: 25605799
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice.
Hattori Y; Kawakami S; Suzuki S; Yamashita F; Hashida M
Biochem Biophys Res Commun; 2004 May; 317(4):992-9. PubMed ID: 15094367
[TBL] [Abstract][Full Text] [Related]
9. Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucleotides.
Hiraoka K; Yamamoto S; Otsuru S; Nakai S; Tamai K; Morishita R; Ogihara T; Kaneda Y
J Immunol; 2004 Oct; 173(7):4297-307. PubMed ID: 15383558
[TBL] [Abstract][Full Text] [Related]
10. Enhanced in vivo gene expression mediated by listeriolysin O incorporated anionic LPDII: Its utility in cytotoxic T lymphocyte-inducing DNA vaccine.
Sun X; Provoda C; Lee KD
J Control Release; 2010 Dec; 148(2):219-25. PubMed ID: 20620181
[TBL] [Abstract][Full Text] [Related]
11. The combination of TLR-9 adjuvantation and electroporation-mediated delivery enhances in vivo antitumor responses after vaccination with HPV-16 E7 encoding DNA.
Ohlschläger P; Spies E; Alvarez G; Quetting M; Groettrup M
Int J Cancer; 2011 Jan; 128(2):473-81. PubMed ID: 20309939
[TBL] [Abstract][Full Text] [Related]
12. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
[TBL] [Abstract][Full Text] [Related]
13. CpG motifs as immune adjuvants.
Klinman DM; Barnhart KM; Conover J
Vaccine; 1999 Jan; 17(1):19-25. PubMed ID: 10078603
[TBL] [Abstract][Full Text] [Related]
14. Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12.
Schirmbeck R; Reimann J
Intervirology; 2001; 44(2-3):115-23. PubMed ID: 11509872
[TBL] [Abstract][Full Text] [Related]
15. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity.
Suzuki Y; Wakita D; Chamoto K; Narita Y; Tsuji T; Takeshima T; Gyobu H; Kawarada Y; Kondo S; Akira S; Katoh H; Ikeda H; Nishimura T
Cancer Res; 2004 Dec; 64(23):8754-60. PubMed ID: 15574787
[TBL] [Abstract][Full Text] [Related]
16. Immunology of DNA vaccines: CpG motifs and antigen presentation.
Manders P; Thomas R
Inflamm Res; 2000 May; 49(5):199-205. PubMed ID: 10893042
[TBL] [Abstract][Full Text] [Related]
17. Effects of multiple copies of CpG on DNA vaccination.
Zhang A; Jin H; Zhang F; Ma Z; Tu Y; Ren Z; Zhang X; Zhu K; Wang B
DNA Cell Biol; 2005 May; 24(5):292-8. PubMed ID: 15869406
[TBL] [Abstract][Full Text] [Related]
18. DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime/protein boost strategy.
Kennedy NJ; Spithill TW; Tennent J; Wood PR; Piedrafita D
Vaccine; 2006 Feb; 24(7):970-9. PubMed ID: 16242220
[TBL] [Abstract][Full Text] [Related]
19. Induction of humoral and cellular immune responses by antigen-expressing immunostimulatory liposomes.
Amidi M; van Helden MJ; Tabataei NR; de Goede AL; Schouten M; de Bot V; Lanzi A; Gruters RA; Rimmelzwaan GF; Sijts AJ; Mastrobattista E
J Control Release; 2012 Dec; 164(3):323-30. PubMed ID: 22940204
[TBL] [Abstract][Full Text] [Related]
20. Plasmid DNA vaccines are effective in the absence of IFNgamma.
Hassett DE; Zhang J; Whitton JL
Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
